An Unbiased View of sustained release and controlled release formulation
The BimSR implant was made to target drug delivery straight to the iris and ciliary human body, thus altering matrix metalloprotein generation and decreasing extracellular matrix in outflow tissues[65]–[66]. By upregulating this pathway, drug distribution is restricted to the suitable tissue targets Hence lowering the incidence of adverse outcome